Concurrent Autophagy Inhibition Overcomes the Resistance of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Human Bladder Cancer Cells

By Kang Minyong   Lee Kyoung-Hwa   Lee Hye Sun   Jeong Chang Wook   Kwak Cheol   Kim Hyeon Hoe   Ku Ja Hyeon  

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-02 ,pp. : 321-321

MDPI

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Mutations as a Prognostic Factor in Korean Patients with Advanced Lung Adenocarcinoma Who Had Not Been Treated with Received Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

By  

Chemotherapy, Vol. 57, Iss. 2, 2011-03 ,pp. : 108-114

Karger

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor in Pancreatic Cancer

By Oliveira-Cunha Melissa   Newman William G.   Siriwardena Ajith K.  

Cancers, Vol. 3, Iss. 2, 2011-03 ,pp. : 1513-1526

MDPI

Access to resources Recommend Favorite

The Clinical Significance of the Insulin-Like Growth Factor-1 Receptor Polymorphism in Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation

By Liu Tu-Chen   Hsieh Ming-Ju   Liu Ming-Che   Chiang Whei-Ling   Tsao Thomas Chang-Yao   Yang Shun-Fa  

International Journal of Molecular Sciences, Vol. 17, Iss. 5, 2016-05 ,pp. : 763-763

MDPI

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver Cancer

By Berasain Carmen   Latasa María Ujue   Urtasun Raquel   Goñi Saioa   Elizalde María   Garcia-Irigoyen Oihane   Azcona María   Prieto Jesús   Ávila Matías A.  

Cancers, Vol. 3, Iss. 2, 2011-05 ,pp. : 2444-2461

MDPI

Access to resources Recommend Favorite